Planta Med 2003; 69(9): 795-799
DOI: 10.1055/s-2003-43201
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Antinociceptive Profile of (-)-Spectaline: A Piperidine Alkaloid from Cassia leptophylla

Magna Suzana Alexandre-Moreira2 , Claudio Viegas Jr.1 , 2 , Ana Luisa Palhares de Miranda2 , Vanderlan da Silva Bolzani1 , Eliezer J. Barreiro2
  • 1NuBBE-Núcleo de Bioensaios, Biossíntese e Ecofisiologia de Produtos Naturais, Universidade Estadual Paulista, Instituto de Química, SP, Brasil
  • 2LASSBio-Laboratório de Avaliação e Síntese de Substâncias Bioativas, Departamento de Fármacos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, RJ, Brasil
Further Information

Publication History

Received: December 10, 2002

Accepted: May 15, 2003

Publication Date:
04 November 2003 (online)

Preview

Abstract

The antinociceptive activity of (-)-spectaline (1), a piperidine alkaloid isolated from Cassia leptophylla Vog. (Leguminosae), was investigated. We have also studied the acute oral toxicity of 1 in mice and it did not show any signals of toxicity in doses lower than 400 μmol/kg. The antinociceptive effect of 1 was evaluated on chemical (acetic acid, formalin and capsaicin) and thermal (hot plate and tail flick) pain models in mice, using classical standard drugs. Dipyrone ID50 = 14.68 μmol/kg (4.8 mg/kg), indomethacin ID50 = 0.78 μmol/kg (0.28 mg/kg) and (-)-spectaline ID50 = 48.49 μmol/kg (15.75 mg/kg), all produced a significant inhibition of acetic acid-induced abdominal writhing in mice. (-)-Spectaline was inactive in the hyperalgesic model of formalin and did not show any central analgesic activity (hot plate and tail flick models). In the capsaicin-induced neurogenic pain model, (-)-spectaline presented an important inhibitory effect with an ID50 = 20.81 μg/paw and dipyrone ID50 = 19.89 μg/paw. The ensemble of results permitted us to identify 1 as an antinociceptive compound. The mechanism underlying this antinociceptive effect of 1 remains unknown, but the results suggest that such an effect could be related to pathways associated to vanilloid receptor systems.

References

Dr. Eliezer J. Barreiro

LASSBio

UFRJ

C.P. 68006.

CEP 21944-910- Rio de Janeiro

RJ

Brazil

Phone: +55-21-22609192 ext. 220/223/238.

Fax: +55-21-22602299

Email: eliezer@pharma.ufrj.br